SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review.

Núñez-Núñez, M; Navarro, MD; Gkolia, P; Babu Rajendran, N; Del Toro, MD; Voss, A; Sharland, M; Sifakis, F; Tacconelli, E; Rodríguez-Baño, J; et al. Núñez-Núñez, M; Navarro, MD; Gkolia, P; Babu Rajendran, N; Del Toro, MD; Voss, A; Sharland, M; Sifakis, F; Tacconelli, E; Rodríguez-Baño, J; and Members of the EPI-NET group on behalf of COMBACTE-MAGNET Co (2017) Surveillance Systems from Public Health Institutions and Scientific Societies for Antimicrobial Resistance and Healthcare-Associated Infections in Europe (SUSPIRE): protocol for a systematic review. BMJ Open, 7 (3). e014538. ISSN 2044-6055 https://doi.org/10.1136/bmjopen-2016-014538
SGUL Authors: Sharland, Michael Roy

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (481kB) | Preview

Abstract

INTRODUCTION: The worldwide spread of antimicrobial resistance is now recognised as a global public health threat. Owing to the geographical heterogeneity, complexity and continuously evolving dynamics of resistant organisms and genes, surveillance is a key tool for understanding, measuring and informing actions in the fight against this problem. To date there is no harmonisation of key indicators or of methodologies used to obtain them. METHODS AND ANALYSIS: The main objective of this project is to systematically review and analyse the current publicly available surveillance activities on antimicrobial resistance and healthcare-associated infections in Europe. Eligible activities are those endorsed by regional, national or transnational health organisations and scientific societies providing data on a periodic basis. Grey and peer-reviewed literature will be searched with no language restrictions. Three independent reviewers will perform a two-step selection process using a previously piloted, tailored electronic data extraction form. Descriptive summaries and tables of all relevant findings will be performed and reported according to PRISMA guidelines. ETHICS AND DISSEMINATION: We did not seek ethical approval for this study because the data to be collected are not linked to individuals. Data will be presented at international conferences and published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: CRD42016033867.

Item Type: Article
Additional Information: This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Keywords: Antimicrobial resistance, healthcare-associated infections, surveillance
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: BMJ Open
ISSN: 2044-6055
Language: eng
Dates:
DateEvent
27 March 2017Published Online
1 March 2017Published
31 January 2017Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
115737Innovative Medicines InitiativeUNSPECIFIED
FP7/2007/2013European Union Seventh Framework ProgrammeUNSPECIFIED
PubMed ID: 28348192
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/108772
Publisher's version: https://doi.org/10.1136/bmjopen-2016-014538

Actions (login required)

Edit Item Edit Item